Cargando…
Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal
PURPOSE: The aim of this study was to evaluate the efficacy and toxicity of high-dose-rate brachytherapy (HDR-BT) boost in anal squamous cell carcinoma (ASCC). MATERIAL AND METHODS: This was a monocentric retrospective study involving patients treated by external irradiation (± chemotherapy), with H...
Autores principales: | Bertin, Emilien, Benezery, Karen, Kee, Daniel Lam Cham, François, Eric, Evesque, Ludovic, Gautier, Mathieu, Gerard, Jean-Pierre, Hannoun-Levi, Jean-Michel, Falk, Alexander T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335558/ https://www.ncbi.nlm.nih.gov/pubmed/30662475 http://dx.doi.org/10.5114/jcb.2018.81025 |
Ejemplares similares
-
Interstitial high-dose rate brachytherapy as boost for anal canal cancer
por: Falk, Alexander Tuan, et al.
Publicado: (2014) -
Mitomycin and 5‐fluorouracil for second‐line treatment of metastatic squamous cell carcinomas of the anal canal
por: Saint, Angélique, et al.
Publicado: (2019) -
Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2-T3 M0: The time/dose factor influence
por: Benezery, Karen, et al.
Publicado: (2020) -
High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes
por: le Guyader, Maud, et al.
Publicado: (2021) -
Concomitant cervical and transperineal parametrial high-dose-rate brachytherapy boost for locally advanced cervical cancer
por: Bailleux, Caroline, et al.
Publicado: (2016)